HumulonCAS# 23510-81-8 |
- Humulone
Catalog No.:BCN2682
CAS No.:26472-41-3
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 23510-81-8 | SDF | Download SDF |
| PubChem ID | 442911 | Appearance | Powder |
| Formula | C21H30O5 | M.Wt | 362.5 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (6R)-3,5,6-trihydroxy-2-(3-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one | ||
| SMILES | CC(C)CC(=O)C1=C(C(=C(C(C1=O)(CC=C(C)C)O)O)CC=C(C)C)O | ||
| Standard InChIKey | VMSLCPKYRPDHLN-OAQYLSRUSA-N | ||
| Standard InChI | InChI=1S/C21H30O5/c1-12(2)7-8-15-18(23)17(16(22)11-14(5)6)20(25)21(26,19(15)24)10-9-13(3)4/h7,9,14,23-24,26H,8,10-11H2,1-6H3/t21-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Humulon Dilution Calculator
Humulon Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.7586 mL | 13.7931 mL | 27.5862 mL | 55.1724 mL | 68.9655 mL |
| 5 mM | 0.5517 mL | 2.7586 mL | 5.5172 mL | 11.0345 mL | 13.7931 mL |
| 10 mM | 0.2759 mL | 1.3793 mL | 2.7586 mL | 5.5172 mL | 6.8966 mL |
| 50 mM | 0.0552 mL | 0.2759 mL | 0.5517 mL | 1.1034 mL | 1.3793 mL |
| 100 mM | 0.0276 mL | 0.1379 mL | 0.2759 mL | 0.5517 mL | 0.6897 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- MEN 11270
Catalog No.:BCC6094
CAS No.:235082-52-7
- Axillaridine
Catalog No.:BCN2060
CAS No.:23506-96-9
- Peimine
Catalog No.:BCN1094
CAS No.:23496-41-5
- Hoechst 33258 analog 5
Catalog No.:BCC1627
CAS No.:23491-55-6
- Hoechst 33258 analog 2
Catalog No.:BCC1625
CAS No.:23491-54-5
- Hoechst 33342
Catalog No.:BCC1629
CAS No.:23491-52-3
- Hoechst 33258
Catalog No.:BCC1623
CAS No.:23491-45-4
- 2-Amino-5-mercapto-1,3,4-thiadiazole
Catalog No.:BCC8536
CAS No.:2349-67-9
- U 99194 maleate
Catalog No.:BCC7029
CAS No.:234757-41-6
- 2-Palmitoylglycerol
Catalog No.:BCC7289
CAS No.:23470-00-0
- trans-Khellactone
Catalog No.:BCN6920
CAS No.:23458-04-0
- Decursinol
Catalog No.:BCN2638
CAS No.:23458-02-8
- 8-Gingerol
Catalog No.:BCN5921
CAS No.:23513-08-8
- 6-Gingerol
Catalog No.:BCN1030
CAS No.:23513-14-6
- 10-Gingerol
Catalog No.:BCN5922
CAS No.:23513-15-7
- (-)-licarin A
Catalog No.:BCN5087
CAS No.:23518-30-1
- Vomifoliol
Catalog No.:BCN5088
CAS No.:23526-45-6
- 5-Aza-2'-deoxycytidine
Catalog No.:BCN2169
CAS No.:2353-33-5
- 8-Debenzoylpaeoniflorin
Catalog No.:BCC8787
CAS No.:23532-11-8
- Daunorubicin HCl
Catalog No.:BCC5083
CAS No.:23541-50-6
- Hoechst 33258 analog 3
Catalog No.:BCC1626
CAS No.:23554-98-5
- HOE 32020
Catalog No.:BCC1620
CAS No.:23554-99-6
- Hoechst 34580
Catalog No.:BCC1632
CAS No.:23555-00-2
- Procyanidin B3
Catalog No.:BCN6316
CAS No.:23567-23-9
Selective Inhibition of Human AKR1B10 by n-Humulone, Adhumulone and Cohumulone Isolated from Humulus lupulus Extract.[Pubmed:30469331]
Molecules. 2018 Nov 21;23(11). pii: molecules23113041.
Hop-derived compounds have been subjected to numerous biomedical studies investigating their impact on a wide range of pathologies. Isomerised bitter acids (isoadHumulone, isocoHumulone and isoHumulone) from hops, used in the brewing process of beer, are known to inhibit members of the aldo-keto-reductase superfamily. Aldo-keto-reductase 1B10 (AKR1B10) is upregulated in various types of cancer and has been reported to promote carcinogenesis. Inhibition of AKR1B10 appears to be an attractive means to specifically treat RAS-dependent malignancies. However, the closely related reductases AKR1A1 and AKR1B1, which fulfil important roles in the detoxification of endogenous and xenobiotic carbonyl compounds oftentimes crossreact with inhibitors designed to target AKR1B10. Accordingly, there is an ongoing search for selective AKR1B10 inhibitors that do not interact with endogeneous AKR1A1 and AKR1B1-driven detoxification systems. In this study, unisomerised alpha-acids (adHumulone, coHumulone and n-Humulone) were separated and tested for their inhibitory potential on AKR1A1, AKR1B1 and AKR1B10. Also AKR1B10-mediated farnesal reduction was effectively inhibited by alpha-acid congeners with Ki-values ranging from 16.79 +/- 1.33 microM (adHumulone) to 3.94 +/- 0.33 microM (n-Humulone). Overall, alpha-acids showed a strong inhibition with selectivity (115(-)137 fold) for AKR1B10. The results presented herein characterise hop-derived alpha-acids as a promising basis for the development of novel and selective AKR1B10-inhibitors.
Humulone suppresses replication of respiratory syncytial virus and release of IL-8 and RANTES in normal human nasal epithelial cells.[Pubmed:23381605]
Med Mol Morphol. 2013 Dec;46(4):203-9.
Respiratory syncytial virus (RSV) is the major infectious agent causing serious respiratory tract inflammation in infants and young children. However, an effective vaccine and anti-viral therapy for RSV infection have not yet been developed. Hop-derived bitter acids have potent pharmacological effects on inflammation. Therefore, we investigated the effects of Humulone, which is the main constituent of hop bitter acids, on the replication of RSV and release of the proinflammatory cytokine IL-8 and chemokine RANTES in RSV-infected human nasal epithelial cells (HNECs). We found that Humulone prevented the expression of RSV/G-protein, formation of virus filaments and release of IL-8 and RANTES in a dose-dependent manner in RSV-infected HNECs. These findings suggest that Humulone has protective effects against the replication of RSV, the virus assembly and the inflammatory responses in HNECs and that it is a useful biological product for the prevention and therapy for RSV infection.
